Comparative effects of acute vs. chronic oral amiodarone treatment during acute myocardial infarction in rats

Europace

Volumn 9, Issue 11, 2007, Pages 1099-1104

  Kolettis, Theofilos M ^a   Agelaki, Maria G ^a   Baltogiannis, Giannis G ^a   Vlahos, Antonios P ^a   Mourouzis, Iordanis ^b   Fotopoulos, Andreas ^a   Pantos, Constantinos ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Amiodarone; Catecholamines; Loading dosage; Mortality; Myocardial infarction; Ventricular tachyarrhythmias

Indexed keywords

AMIODARONE; CATECHOLAMINE; NORADRENALIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIARRHYTHMIC AGENT;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARRHYTHMOGENESIS; ARTICLE; BRADYCARDIA; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; FEMALE; HEART FAILURE; HEART INFARCTION SIZE; HEART RATE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; TREATMENT DURATION; ANIMAL; BLOOD; COMPARATIVE STUDY; DOSE RESPONSE; ELECTROCARDIOGRAPHY; HEART INFARCTION; ORAL DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; WISTAR RAT;

ADMINISTRATION, ORAL; ADRENERGIC ALPHA-AGONISTS; AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CATECHOLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; MYOCARDIAL INFARCTION; NOREPINEPHRINE; RANDOM ALLOCATION; RATS; RATS, WISTAR; TACHYCARDIA, VENTRICULAR;

EID: 40049107476     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum196     Document Type: Article

References (27)

1. Connolly SJ. Evidence-based analysis of amiodarone efficacy and safety. Circulation 1999;100:2025-34.
2. Nattel S, Talajic M, Fermini B, Roy D. Amiodarone: pharmacology, clinical actions and relationships between them. J Cardiovasc Pharmacol 1992;3:266-80.
3. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997;350:1417-24.
4. Desai AD, Chun S, Sung RJ. The role of intravenous amiodarone in the management of cardiac arrhythmias. Ann Intern Med 1997;127:294- 303.
5. Andreasen F, Agerbaek H, Bjerregaard P, Gotzsche H. Pharmacokinetics of amiodarone after intravenous and oral administration. Eur J Clin Pharmacol 1981;19:293-9.
6. Schwartz A, Shen E, Morady F, Gillespie K, Scheinman M, Chatterjee K. Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardia. Am Heart J 1983;106:848-56.
7. Kannan R, Nademanee K, Hendrickson JA, Rostami HJ, Singh BN. Amiodarone kinetics after oral doses. Clin Pharmacol Ther 1982;31:438-44.
8. Singh BN, Nademanee K, Kannan R, Ikeda N. The clinical results of amiodarone in cardiac arrhythmias: optimal dosing. Pacing Clin Electrophysiol 1984;7:109-24.
9. Finance O, Manning A, Chatelain P. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D, L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. J Cardiovasc Pharmacol 1995;26:570-6.
10. Manning A, Thisse V, Hodeige D, Richard J, Heyndrickx JP, Chatelain P. SR 33589, a new amiodarone-like antiarrhythmic agent: electrophysiological effects in anesthetized dogs. J Cardiovasc Pharmacol 1995;25:252-61.
11. Kodama I, Kamiya K, Toyama J. Cellular electropharmacology of amiodarone. Cardiovasc Res 1997;35:13-29.
12. Agelaki MG, Pantos C, Korantzopoulos P, Tsalikakis DG, Baltogiannis GG, Fotopoulos A et al. Comparative antiarrhythmic efficacy of amiodarone and dronedarone during acute myocardial infarction in rats. Eur J Pharmacol 2007;564:150-7.
13. Opitz CF, Mitchell GF, Pfeffer MA, Pfeffer JM. Arrhythmias and death after coronary artery occlusion in the rat. Continuous telemetric ECG monitoring in conscious, untethered rats. Circulation 1995;92:253-61.
14. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979;44:503-12.
15. Ytrehus K, Liu Y, Tsuchida A, Miura T, Liu GS, Yang XM et al. Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am J Physiol 1994;267:H2383-90.
16. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res 1988;22:447-55.
17. Curtis MJ, Walker MJA. Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischemia. Cardiovasc Res 1988;22:656-65.
18. Clements-Jewery H, Hearse DJ, Curtis MJ. Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation. Br J Pharmacol 2005;145:551-64.
19. Johnston KM, MacLeod BA, Walker MJ. Responses to ligation of a coronary artery in conscious rats and the actions of antiarrhythmics. Can J Physiol Pharmacol 1983;61:1340-53.
20. Au TL, Curtis MJ, Walker MJ. Effects of (-), (+/2), and (+) verapamil on coronary occlusion-induced mortality and infarct size. J Cardiovasc Pharmacol 1987;10:327-31.
21. Connolly SJ. Evidence-based analysis of amiodarone efficacy and safety. Circulation 1999;100:2025-34.
22. Nagasawa Y, Chen J, Hashimoto K. Antiarrhythmic properties of a prior oral loading of amiodarone in in vivo canine coronary ligation/reperfusion-induced arrhythmia model: comparison with other class III antiarrhythmic drugs. J Pharmacol Sci 2005;97:393-9.
23. Escoubet B, Coumel P, Poirier JM, Maison-Blanche P, Jaillon P, Leclercq JF et al. Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations. Am J Cardiol 1985;55:696-702.
24. Coumel P, Fidelle J. Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases. Am Heart J 1980;100:438-44.
25. Rakita L, Sobol SM. Amiodarone in the treatment of refractory ventricular arrhythmias. JAMA 1983;250:1293-5.
26. Kaye DM, Dart AM, Jennings GL, Esler MD. Antiadrenergic effect of chronic amiodarone therapy in human heart failure. J Am Coll Cardiol 1999;33:1553-9.
27. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.